Iwata H, Yamamoto Y, Sakai T, Hasegawa Y, et al. Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy. Breast Cancer Res Treat 2023 Mar 22. doi: 10.1007/s10549-023-06874.
PMID: 36947277